基本信息
views: 520
Career Trajectory
Bio
Our research group aims to understand the roles that proteins play in human physiological and pathological processes and to use this knowledge to identify novel therapeutic targets and drugs to treat disease. To achieve these goals, we develop and apply new technologies that bridge the fields of chemistry and biology, ascribing to the philosophy that the most significant biomedical problems require creative multidisciplinary approaches for their solution. Our technological innovations address fundamental challenges in human physiology and disease that are beyond the scope of contemporary methods. For instance, enzymes are tightly regulated by post-translational events in vivo, meaning that their activity may not correlate with expression as measured by standard genomic and proteomic approaches. Considering that it is an enzyme's activity, rather than abundance that ultimately dictates its role in cell physiology and pathology, we have introduced a set of proteomic technologies that directly measures this parameter. These activity-based protein profiling (ABPP) methods exploit the power of chemistry to engender new tools and assays for the global analysis of enzyme activities. The enzyme activity profiles generated by ABPP constitute unique molecular portraits of cells and tissues that illuminate how metabolic and signaling networks are regulated in vivo. Additionally, by evaluating enzymes based on functional properties rather than mere abundance, ABPP acquires high-content proteomic information that is enriched in novel markers and targets for the diagnosis and treatment of human disease. We have also shown that ABPP can serve as a near-universal assay for the discovery of small-molecule inhibitors or ligands of proteins directly in native biological systems and, through doing so, greatly expand the scope of proteins that can be targeted by chemical probes and drugs.
Research Interests
Papers共 799 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Zhonglin Liu,Jarrett R. Remsberg,Haoxin Li,Evert Njomen,Kristen E. Demeester,Yongfeng Tao,Guoqin Xia, Rachel E. Hayward,Minjin Yoo, Tracey Nguyen,Gabriel M. Simon,Stuart L. Schreiber,
JOURNAL OF THE AMERICAN CHEMICAL SOCIETYno. 15 (2024): 10393-10406
Daisuke Ogasawara,David B. Konrad,Zher Yin Tan,Kimberly L. Carey, Jessica Luo,Sang Joon Won,Haoxin Li, Trever Carter,Kristen E. DeMeester,Evert Njomen,Stuart L. Schreiber,Ramnik J. Xavier,
bioRxiv the preprint server for biology (2024)
Yuanjin Zhang, Zhonglin Liu, Marsha Hirschi,Oleg Brodsky,Eric Johnson,Sang Joon Won,Asako Nagata, Matthew D. Petroski,Jaimeen D. Majmudar,Sherry Niessen,Todd VanArsdale,Adam M. Gilbert,
biorxiv(2024)
Rebecca Chan,Xujun Cao, Sabrina L Ergun,Evert Njomen, Stephen R. Lynch,Christopher Ritchie,Benjamin Cravatt,Lingyin Li
biorxiv(2024)
Gloria Asantewaa, Emily T. Tuttle,Nathan P. Ward, Yun P. Kang,Yumi Kim,Madeline Kavanagh, Aaron R. Huber,Joshua Munger,Benjamin Cravatt,Calvin L. Cole,Gina M. DeNicola,Isaac S. Harris
Cancer Researchno. 7_Supplement (2024)
Isaac O Akefe,Saber H Saber,Benjamin Matthews,Bharat G Venkatesh,Rachel S Gormal,Daniel G Blackmore,Suzy Alexander, Emma Sieriecki,Yann Gambin, Jesus Bertran-Gonzalez, Nicolas Vitale,Yann Humeau,
The EMBO journalno. 4 (2024): 533-567
Cancer Researchno. 6_Supplement (2024): 1655-1655
Alexis F. League,Barkha J. Yadav-Samudrala, Ramya Kolagani, Calista A. Cline,Ian R. Jacobs,Jonathan Manke,Micah J. Niphakis,Benjamin F. Cravatt,Aron H. Lichtman,Bogna M. Ignatowska-Jankowska,Sylvia Fitting
FRONTIERS IN IMMUNOLOGY (2024): 1374301-1374301
Sang Joon Won,Yuxiang Zhang, Christopher J Reinhardt, Nicole S MacRae, Kristen E DeMeester,Evert Njomen, Lauren M Hargis,Jarrett R Remsberg,Bruno Melillo,Benjamin F Cravatt,Michael A Erb
bioRxiv : the preprint server for biology (2024)
ISRAEL JOURNAL OF CHEMISTRY (2023)
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn